REFETIB
Film-coated tablet, 250mg
RxActive license
Active substance (INN)
gefitinib
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength250mg
PackagingUkupno 30 film tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerRemedica Ltd., Cyprus
Therapeutic groupAntineoplastic and immunomodulating agents (L01EB01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU, PROMET I USLUGE "PONTERA PHARMA SOLUTIONS" DOO PODGORICA
Authorization dateDecember 16, 2024
Analogs in Montenegro
2Other medicines with the same active substance
Source: CInMED register